CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $3.2M invested in Can-Fite BioPharma in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$592K
2
+$571K
3
+$347K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$58K
5
BG
Bollard Group
Massachusetts
+$32K

Top Sellers

1
-$30.5K
2
-$11K
3
-$3.43K
4
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.01M
2
$592K
3
$347K
4
$61K
5
$58K
6
$51K
7
$32K
8
$25K
9
$16K
10
$4K
11
–
12
–